AIR-001 MD dose level 3 clinical trials

A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)

This study is testing a new medicine called AIR-001 for adults with a genetic lung condition called Alpha-1 Antitrypsin Deficiency (AATD). Doctors want to see how safe it is and how the body handles different doses.